← 治験一覧に戻る
TRK-700とジゴキシンおよびミダゾラムとの薬物相互作用に関する研究
基本情報
- NCT ID
- NCT03043248
- ステータス
- 完了
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 48
- 治験依頼者名
- Toray Industries, Inc
概要
This study comprises 2 cohorts, and in each cohort, the study will be conducted as an open-label add-on study. The purpose of the study is to investigate the pharmacokinetics of each substrate in concomitant administration of a single dose of the P-glycoprotein substrate digoxin (Cohort A) or the CYP3A4 substrate midazolam (Cohort B) during repeated administration of TRK-700 in healthy adult males.
対象疾患
Healthy
介入
TRK-700(DRUG)
Digoxin(DRUG)
Midazolam(DRUG)
依頼者(Sponsor)
Toray Industries(INDUSTRY)